Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C ( r 800 mg TID incombination with PEGINT...)

Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C

r 800 mg TID in combination with PEGINTRON and REBETOL in patients chronically infected with HCV genotype 1 who were nonresponders to previous peginterferon and ribavirin combination therapy. The study involves approximately 350 patients at centers in the United States and Europe. All study participants have completed treatment and are in the follow-up phase. Sustained virological response data from this study will be available later in 2007, and will help guide future clinical development of boceprevir.

Key Data Presentations at EASL

Peginterferon Alfa-2b and Ribavirin for 14 or 24 Weeks in Patients with HCV Genotype 2 or 3 and Rapid Virological Response, The North-C Trial. Dalgard, O. et al. Oral presentation, Sunday, April 15, at 13:15, General Session 4.

A Pegylated Interferon Alfa-2b Dose Reduction in HCV 1B Patients with Rapid Viral Response Does Not Affect Sustained Virological Response. Napoli, N. et al. Poster presentation, Thursday, April 12.

Comparison of Early Virologic Response Among Patients with Chronic Hepatitis C Infected with Genotype Non 2/3 Treated with Pegylated Interferon Alfa-2b and Ribavirin in Dependence with Hepatic Fibrosis Stages. Berak, H. et al. Poster presentation, Thursday, April 12.

Combination of Two Hepatitis C Virus Inhibitors, SCH 503034 (Boceprevir) and NM107 (the active moiety of NM283, valopicitabine), Provides Enhanced Anti-Replicon Activity and Suppresses Emergence of Resistant Replicons. Ralston, R. et al. Late-breaker poster presentation, Thursday, April 12.

Favorable Cross-Resistance Profile of Two Novel Hepatitis C Virus Inhibitors, SCH 503034 (Boceprevir) and HCV-796, and Enhanced Anti-Replicon Activity Mediated by the Combined Use of Both Compounds. Howe, A.Y. et al. Poster presentation Thursday, April 12.

SCH 503034 (Boceprevir), an Oral HCV Protease Inhibitor, is Well Tolerated in Patients with Varying Degrees of Hepatic Impairment. Preston, R.A., et al. Poster present
'"/>

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
2. Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
3. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
7. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
8. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
9. Major Manufacturer of Unapproved and Adulterated Drugs
10. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings

Post Your Comments:

(Date:5/21/2013)... May 21, 2013 Decision Resources, one ... firms for pharmaceutical and healthcare issues, finds ... on key efficacy endpoints, including overall survival ... most influence over surveyed U.S. and European ... positive, HER2-negative breast cancer. The two novel ...

(Date:5/21/2013)... , May 21, 2013 iHealth ... manufacture of wireless personal healthcare products and a ... reach, announcing the release of two new fitness ... pressure monitors and scales: the Wireless Pulse Oximeter ... (Photo: http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth ...

(Date:5/21/2013)... FREDERICK, Md. , May 21, 2013 /PRNewswire/ ... inexpensive, disposable drug-free consumer electronic devices, announced that ... is presenting today to the FDA,s Medical Advisory ... reclassifying the company,s products for over the counter ... the FDA developed its medical device classification schema," ...

Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 2 iHealth Lab adds new products and partners to mobile personal healthcare offering 3 BioElectronics Presents FDA Reclassification Panel 2 BioElectronics Presents FDA Reclassification Panel 3

[0] Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer [0] iHealth Lab adds new products and partners to mobile personal healthcare offering [0] BioElectronics Presents FDA Reclassification Panel

... 26 Todd Bluedorn, chief executive officer of Lennox International ... at the J.P. Morgan HVAC Conference on Thursday, May 28 ... presentation materials can be accessed on the company,s website at ... archived for 60 days. The webcast can also be ...

... Health, Inc. (TH) is pleased to announce its involvement in ... Komen Foundation. TH,s collaborator, Duke University , was ... million of investment by the foundation in 2009 to further ... cancer.The Susan G. Komen for the Cure(R) is a nonprofit ...

Cached Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2 Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3

Lennox International to Present at J.P. Morgan Conference Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R)

(Date:5/21/2013)... A new study appearing in the current ... cells harvested from fat (adipose) are more potent than ... the body’s immune system. , The finding could ... adipose tissue-derived stem cells (AT-SCs) are far more plentiful ... and can be collected from waste material from liposuction ...

(Date:5/21/2013)... Australia (PRWEB) May 22, 2013 About ... made the Fertility Clinics industry one of ... industry assists patients who are unable to conceive naturally ... and popular of which is in-vitro fertilisation (IVF) cycles. ... IVF cycles in Australia has increased by 4.4% per ...

(Date:5/21/2013)... in St. Louis announced today that it is ... by the Bill & Melinda Gates Foundation. Tae ... & chemical engineering, will pursue an innovative global ... of Parasite Eggs by Probiotic Organisms." , Grand ... ideas that can break the mold in how ...

(Date:5/21/2013)... Dayton, OH (PRWEB) May 21, 2013 ... is associated with an increased risk for CKD progression ... at Dayton Children’s Hospital and Johns Hopkins University has ... disease who are exposed to secondhand smoke. , ... years is the first study of the effect of ...

(Date:5/21/2013)... Columbia, MO (PRWEB) May 21, 2013 The ... 2,500 athletes and coaches from across the state to Columbia. ... campuses of the University of Missouri and Columbia College, and ... , The State Summer Games officially kick off at 7:30 ... Ceremony will feature a Go Wild! theme, the Parade of ...

Breaking Medicine News(10 mins):Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2 Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3 Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 2 Health News:Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld 3 Health News:Gates Fellowship addresses parasite infection in developing world 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 2 Health News:Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study 3 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2 Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3

[0] Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease [0] Fertility Clinics in Australia Industry Market Research Report Now Available from IBISWorld [0] Gates Fellowship addresses parasite infection in developing world [0] Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study [0] Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia

... demands the immediate release of three Sri Lankan physicians whom the Sri ... ... (Vocus) May 18, 2009 -- Physicians for Human Rights (PHR) ... Lankan Army (SLA) detained on May 16, 2009. A Minister of Health ...

... (Nasdaq: BJGP ) ("BMP Sunstone" or the "Company"), today ... , Financial Highlights from the First Quarter Ended ... to $39.3 million from $18.1 million in, ... profit increased to $20.7 million from $7.7 million in the prior, ...

... 18 Beckman Coulter, Inc. (NYSE: BEC ... that simplify, automate and innovate complex biomedical testing, today ... of its common stock, to finance in part ... of Olympus Corporation,s Life Science business, or the acquisition. ...

... The Quigley Corporation, (Nasdaq: QG L ... , today announced an update on the Company,s ... announcement regarding the unexpected positive finding for its QR-333 ... 11b clinical trial. While the complete statistical results of ...

... suggests that evolution needed only a few genetic changes to ... comparing the fetal development of the eye of the owl ... only a minor difference in the timing of cell proliferation ... of eyes.The findings help scientists understand how a structure as ...

... Cincinnati (UC) cancer and cell biologists have identified a ... prostate cancers. , In a preclinical study ... that simultaneous inactivation of two particular genesknown as ... cancer tumors in mice. , "We knew that ...

Physicians for Human Rights Calls for the Release of Sri Lankan Doctors BMP Sunstone Reports First Quarter 2009 Financial Results Beckman Coulter, Inc. Announces Common Stock Offering The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure New Insight Into Primate Eye Evolution Research reveals molecular pathway behind invasive prostate cancers

MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...

... offers five classes of resectoscope electrodes ... loops, knife, roller bar & ball, ... only electrodes specifically integrated into the ... removal with minimal bleeding, increased visibility, ...

... and MRO™-2005 Rigid Percutaneous Nephroscopes combine ... throughput capacity with proven MRO performance. ... with small size sheaths. The MRO™-20 ... easy positioning during percutaneous procedures. The ...

... Resectoscope is based on the award winning ... the surgeon to perform TURis - resection ... element, HF cable and electrodes, Olympus OES ... in saline, supporting both, standard TUR and ...

Medicine Products:

MT-BT-5011 Prostate Seeding Needle USA Elite System™ & USA Series™ Roller Bar Electrode USA Elite System™ MRO™-20 Rigid Percutaneous Nephroscopes SurgMaster OES Pro Resectoscope